BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the U.S. Food & Drug Administration (FDA) has ...
Knowing when to book an appointment with a pediatric orthopedist instead of a pediatrician can help a child get faster ...
Six-year-old José Capablanca was excited to see his visitors. “I think you guys want to know how fast I can run!” he shouted, racing around his family’s home in Gallatin, Tennessee. José has Duchenne ...
Musculoskeletal disorders affect the bones, joints, muscles, and connective tissue. Many musculoskeletal disorders may occur in children, and some types are more common than others. Musculoskeletal ...
- Study endpoints include safety and tolerability, effect on muscle force and function, and impact on muscle quality and regeneration - Enrollment of first study participant anticipated by end of 2025 ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval SEATTLE, Dec. 11, 2025 /PRNewswire/ -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback